# Todd Sherer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/todd-sherer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,276 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 47 |
| i10-index | 73 |
| Last Known Institution | Michael J. Fox Foundation |
| OpenAlex ID | https://openalex.org/A5088732447 |
| ORCID iD | https://orcid.org/0000-0001-9667-6600 |
| Works | 127 |

## Researcher papers

- [The Emerging Evidence of the Parkinson Pandemic](https://scholariq.org/papers/the-emerging-evidence-of-the-parkinson-pandemic/)
- [The Parkinson Progression Marker Initiative (PPMI)](https://scholariq.org/papers/the-parkinson-progression-marker-initiative-ppmi/)
- [Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study](https://scholariq.org/papers/assessment-of-heterogeneity-among-participants-in-the-parkinson-s-progression/)
- [The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort](https://scholariq.org/papers/the-parkinson-s-progression-markers-initiative-ppmi-establishing-a-pd-biomarker/)
- [A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research](https://scholariq.org/papers/a-biological-definition-of-neuronal-synuclein-disease-towards-an-integrated/)
- [Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort](https://scholariq.org/papers/longitudinal-change-of-clinical-and-biological-measures-in-early-parkinson-s/)
- [Finding useful biomarkers for Parkinson’s disease](https://scholariq.org/papers/finding-useful-biomarkers-for-parkinson-s-disease/)
- [Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study](https://scholariq.org/papers/clinical-and-dopamine-transporter-imaging-characteristics-of-non-manifest-lrrk2/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Nuclear Receptors and Signaling](https://scholariq.org/topics/nuclear-receptors-and-signaling/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)

## Researcher university

- [Michael J. Fox Foundation](https://scholariq.org/institutions/michael-j-fox-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.